PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
1-Year Return
16.62%
This Quarter Return
+11.76%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$4.04B
AUM Growth
-$339M
(-7.7%)
Cap. Flow
-$659M
Cap. Flow
% of AUM
-16.3%
Top 10 Holdings %
Top 10 Hldgs %
52.59%
Holding
160
New
36
Increased
28
Reduced
47
Closed
13
Top Buys
| 1 |
FedEx
FDX
|
$102M |
| 2 |
B
Barrick Mining Corporation
B
|
$76.2M |
| 3 |
Freeport-McMoran
FCX
|
$50.5M |
| 4 |
OCFT
OneConnect Financial Technology
OCFT
|
$27.2M |
| 5 |
Steel Dynamics
STLD
|
$25.4M |
Top Sells
| 1 |
Intel
INTC
|
$138M |
| 2 |
Meta Platforms (Facebook)
META
|
$127M |
| 3 |
Alibaba
BABA
|
$123M |
| 4 |
Skyworks Solutions
SWKS
|
$99.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$82.3M |
Sector Composition
| 1 | Consumer Discretionary | 30.55% |
| 2 | Industrials | 19.46% |
| 3 | Technology | 17.7% |
| 4 | Communication Services | 11.39% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Agios Pharmaceuticals
AGIO
$2.1B
| $2.41M | 0.06% |
68,752
| – | – |
|
77
Merus
MRUS
$5.01B
| $2.29M | 0.06% |
190,408
| – | – |
|
78
Cardinal Health
CAH
$35.7B
| $2.1M | 0.05% |
44,670
| – | – |
|
79
Mersana Therapeutics
MRSN
$35.5M
| $2.07M | 0.05% |
4,436
| – | – |
|
80
Sangamo Therapeutics
SGMO
$160M
| $2.06M | 0.05% |
218,336
-22,176
| -9% | -$210K |
|
81
Analog Devices
ADI
$121B
| $2M | 0.05% |
17,168
+6,448
| +60% | +$753K |
|
82
Oracle
ORCL
$626B
| $1.91M | 0.05% |
31,996
+2,578
| +9% | +$154K |
|
83
LivaNova
LIVN
$3.18B
| $1.88M | 0.05% |
41,603
-30,000
| -42% | -$1.36M |
|
84
Wave Life Sciences
WVE
$1.3B
| $1.75M | 0.04% |
206,384
+80,199
| +64% | +$681K |
|
|
ORTX
85
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.69M | 0.04% |
41,198
+5,496
| +15% | +$226K |
|
|
BCEL
86
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.67M | 0.04% |
+119,751
| New | +$1.67M |
|
87
Dianthus Therapeutics
DNTH
$794M
| $1.64M | 0.04% |
15,091
| – | – |
|
88
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.59M | 0.04% |
462,402
| – | – |
|
|
XLRN
89
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.56M | 0.04% |
13,872
-5,928
| -30% | -$667K |
|
|
FPRX
90
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.54M | 0.04% |
327,414
| – | – |
|
91
Arcus Biosciences
RCUS
$1.23B
| $1.49M | 0.04% |
87,058
| – | – |
|
92
Apple
AAPL
$3.56T
| $1.48M | 0.04% |
12,788
-8,660
| -40% | -$1M |
|
93
Adaptive Biotechnologies
ADPT
$1.98B
| $1.46M | 0.04% |
30,028
-18,862
| -39% | -$917K |
|
94
Cisco
CSCO
$269B
| $1.41M | 0.03% |
35,700
| – | – |
|
95
Roku
ROKU
$14.3B
| $1.4M | 0.03% |
7,398
| – | – |
|
|
INBX
96
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.35M | 0.03% |
+75,000
| New | +$1.35M |
|
97
Ovid Therapeutics
OVID
$91.7M
| $1.34M | 0.03% |
233,413
-68,176
| -23% | -$391K |
|
98
CytomX Therapeutics
CTMX
$346M
| $1.33M | 0.03% |
+200,224
| New | +$1.33M |
|
99
Moderna
MRNA
$9.45B
| $1.31M | 0.03% |
18,528
-12,532
| -40% | -$887K |
|
100
Intellia Therapeutics
NTLA
$1.25B
| $1.29M | 0.03% |
65,031
-18,706
| -22% | -$372K |
|